(Press-News.org) A researcher at the University of Arizona Mel and Enid Zuckerman College of Public Health received a $750,000 National Institutes of Health grant to study the asthma risks associated with the use of cleaning and disinfecting products among nurses.
Cleaning processes in health care facilities involve an inherent “risk-risk tradeoff.” Increased use of cleaning and disinfection products leads to increased work-related asthma risks and simultaneously a decrease in occupational-infection risks.
Preliminary survey data indicate that nurses are generally willing to increase infection risks to maintain lower asthma risks if they think they will recover.
“Translating these concerns into cleaning and disinfection protocol changes is challenging due to logistical constraints and the lack of awareness about asthma risks,” said principal investigator Amanda Wilson, PhD, an assistant professor in the Zuckerman College of Public Health’s Department of Community, Environment and Policy.
Wilson will use the five-year National Heart, Lung and Blood Institute grant to gather data that can advance methodologies for relating tolerable occupational respiratory-disease risks to nurses and guide public health policies.
In 2022, there were more than 3 million registered nurses in the United States and more than 56,000 of them worked in Arizona, according to the U.S. Bureau of Labor Statistics. Asthma affects more than 27 million people in the United States, or about 1 in 12 Americans, according to the Asthma and Allergy Foundation of America.
The study, “Work-related Asthma Risk for Nursing Staff Conducting Cleaning and Disinfection: Translation of Risk-risk Tradeoff Methodology,” is funded through a K01 Mentored Research Scientist Career Development Award that provides support for early-career researchers.
“Dr. Amanda Wilson earned her PhD with us here in the Zuckerman College of Public Health, and she is on her way to becoming an outstanding public health researcher,” said Iman Hakim, MD, PhD, MPH, dean of the Zuckerman College of Public Health. “We are so proud of all she has accomplished. This new award shows that she is on her way to making a real difference in public health and respiratory research.”
Wilson’s mentors from the Zuckerman College of Public Health include adjunct professor Lynn Gerald, PhD; professor Paloma Beamer, PhD; and adjunct professor Phil Harber, MD, MPH. Other mentors include Benjamin Wilfond, MD, of the University of Washington, Susan Chilton of Newcastle University and David Resnik, JD, PhD, of the National Institute of Environmental Health Sciences.
This research is supported in part by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health, under award number K01HL168014.
END
NIH grant funds research on work-related asthma among nurses
A researcher at the Zuckerman College of Public Health will use a $750,000 grant to develop methodology to inform cleaning and disinfecting protocols and help educate nurses about asthma risks.
2024-03-21
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients
2024-03-21
Milan, Italy: A team of international researchers have developed an artificial intelligence (AI) tool that can predict which breast cancer patients may be at risk of side effects after surgery and radiotherapy.
Dr Tim Rattay told the 14th European Breast Cancer Conference (EBCC14) in Milan today (Thursday) that the tool will be tested in a clinical trial that will start recruiting in the last quarter of this year in three countries: France, The Netherlands and the UK.
“It is an explainable AI tool, which means that it shows the reasoning behind its decision-making. This makes it ...
Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence
2024-03-20
A new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2 or 3 HR-positive, HER2-negative early breast cancer lives without the cancer returning, according to a new study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators.
The team found adding ribociclib, a drug that belongs to a class of CDK4/6 inhibitors, to standard hormone therapy not only improved invasive-free survival in women with this type of early-stage breast cancer, but also improves distant disease-free survival and recurrence-free survival.
The results were published today in the New England ...
Social isolation linked to biological age gap, higher mortality rate
2024-03-20
ROCHESTER, Minn. — A new study from Mayo Clinic finds that socially isolated people are more likely to show signs of being biologically older than their age and more likely to die from a variety of causes. The research, published in the Journal of the American College of Cardiology: Advances, suggests that social connection plays an important role in overall physical health and longevity, and it should be addressed as a necessary part of the social determinants of health.
To investigate the role of social contact in biological aging, the ...
New commentary: Combatting digital redlining is imperative for advancing health equity
2024-03-20
Broadband plays a critical role in most aspects of modern-day life, yet over 42 million Americans still lack access to high-speed Internet. This digital divide is driven by “digital redlining”—discriminatory disinvestment in broadband infrastructure that disproportionately affects people of color, low-income communities, and rural populations, worsening disparities in access to healthcare, social services, education, and employment for these populations.
Addressing digital redlining and the digital divide is imperative for ...
Drug-pricing program improved prostate cancer treatment adherence
2024-03-20
ANN ARBOR, Michigan — Prostate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to stick to their prescription drug therapy than patients at other hospitals, according to a study from researchers at the University of Michigan’s Rogel Cancer Center and Institute for Healthcare Policy and Innovation.
The 340B Drug Pricing Program is a federal program that requires the pharmaceutical industry to provide a discount on the cost of drugs to participating hospitals who serve a disproportionate number of Medicare and Medicaid patients. The program was started to enable hospitals to stretch scarce resources, ...
Prenatal exposure to antiseizure medication topiramate may not increase children’s risk of autism spectrum disorder
2024-03-20
Embargoed for release: Wednesday, March 20, 5:00 PM ET
Key points:
In a study of 4.3 million pregnant women and their children, prenatal exposure to topiramate, an antiseizure medication used to treat epilepsy, bipolar disorder, and migraines, was not associated with additional risk of the children developing autism spectrum disorder (ASD).
Consistent with previous research, the study also found that prenatal exposure to valproate and lamotrigine—two other antiseizure medications—were associated with ...
Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial
2024-03-20
An investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy (GAN), was well tolerated and showed signs of therapeutic benefit in a clinical trial led by the National Institutes of Health (NIH). Currently, there is no treatment for GAN and the disease is usually fatal by 30 years of age. Fourteen children with GAN, ages 6 to 14 years, were treated with gene transfer therapy at the NIH Clinical Center and then followed for about six years to assess safety. Results ...
TIFRH study reports scalable and cost-effective method to assemble a safer and durable lithium metal battery
2024-03-20
Lithium metal batteries (LMBs) can provide nearly 10 times higher energy density compared to the present Lithium-ion batteries (LIBs) and hence are identified as one of the potential future storage systems. However, LMBs pose certain safety concerns and cannot be used for fast-charging applications. Uncontrolled dendrite formation, leading to excessive heating and battery short circuit is one of the critical challenges of its advancement.
Researchers have previously attempted to address the safety concerns in LMBs but with methods that were laboursome and money/time intensive. T. N. Narayanan’s lab at the Tata Institute ...
Pediatric cancer research foundation expands executive leadership team
2024-03-20
IRVINE, CA, March 20, 2024 --The Pediatric Cancer Research Foundation (PCRF), a nonprofit focused on transforming pediatric cancer care by funding research breakthroughs, today announced the expansion of its leadership team. Executive Director Jeri Wilson, who has led the organization for 12 years, will step into the newly created role of Vice President of Development, Principal Gifts. Danielle Fragalla, a known nonprofit leader in California, will become Chief Executive Officer.
In the 12 years Ms. Wilson has led the Foundation, it has grown from a grassroots ...
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay
2024-03-20
“These results suggest strong potential for clinical use of the assay in ctDNA monitoring of solid tumor cancers.”
BUFFALO, NY- March 20, 2024 – A new research paper was published in Oncotarget's Volume 15 on March 14, 2024, entitled, “Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.”
In this new study, researchers Josette Northcott, Gabor Bartha, Jason Harris, Conan Li, Fabio C.P. Navarro, Rachel Marty Pyke, Manqing Hong, Qi Zhang, Shuyuan Ma, Tina X. Chen, Janet Lai, Nitin Udar, Juan-Sebastian Saldivar, Erin Ayash, ...
LAST 30 PRESS RELEASES:
Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds
Experts developing immune-enhancing therapies to target tuberculosis
Making transfusion-transmitted malaria in Europe a thing of the past
Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)
CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back
Ancient Maya blessed their ballcourts
Curran named Fellow of SAE, ASME
Computer scientists unveil novel attacks on cybersecurity
Florida International University graduate student selected for inaugural IDEA2 public policy fellowship
Gene linked to epilepsy, autism decoded in new study
OHSU study finds big jump in addiction treatment at community health clinics
Location, location, location
Getting dynamic information from static snapshots
Food insecurity is significant among inhabitants of the region affected by the Belo Monte dam in Brazil
The Society of Thoracic Surgeons launches new valve surgery risk calculators
Component of keto diet plus immunotherapy may reduce prostate cancer
New circuit boards can be repeatedly recycled
Blood test finds knee osteoarthritis up to eight years before it appears on x-rays
April research news from the Ecological Society of America
Antimicrobial resistance crisis: “Antibiotics are not magic bullets”
Florida dolphin found with highly pathogenic avian flu: Report
Barcodes expand range of high-resolution sensor
DOE Under Secretary for Science and Innovation visits Jefferson Lab
Research expo highlights student and faculty creativity
Imaging technique shows new details of peptide structures
MD Anderson and RUSH unveil RUSH MD Anderson Cancer Center
Tomography-based digital twins of Nd-Fe-b magnets
People with rare longevity mutation may also be protected from cardiovascular disease
Mobile device location data is already used by private companies, so why not for studying human-wildlife interactions, scientists ask
Test reveals mice think like babies
[Press-News.org] NIH grant funds research on work-related asthma among nursesA researcher at the Zuckerman College of Public Health will use a $750,000 grant to develop methodology to inform cleaning and disinfecting protocols and help educate nurses about asthma risks.